World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
72
Citations
21100
World Ranking
1729
National Ranking
742

Medicine

D-Index
74
Citations
22170
World Ranking
19358
National Ranking
9638

Francisco M. Marty publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Francisco M. Marty sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 269 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Francisco M. Marty D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Francisco M. Marty sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 72 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Francisco M. Marty was affiliated with Brigham and Women's Hospital in the United States. Their research primarily focused on medicine, with a specialization in epidemiology, infectious diseases, oncology, neurology, and transplantation.

Themes of their scientific work included:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • COVID-19 clinical research studies
  • Cytomegalovirus and herpesvirus research
  • Long-term effects of COVID-19
  • SARS-CoV-2 and COVID-19 research
  • Herpesvirus infections and treatments

They published frequently in the following venues:

  • Open Forum Infectious Diseases
  • New England Journal of Medicine
  • Clinical Infectious Diseases
  • Blood Advances
  • Transplantation and Cellular Therapy

Notable recent papers included:

  • Remdesivir for 5 or 10 Days in Patients with Severe Covid-19, 2020, New England Journal of Medicine
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19, 2020, JAMA
  • Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients, 2021, New England Journal of Medicine
  • Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial, 2021, Clinical Infectious Diseases
  • How to Obtain a Nasopharyngeal Swab Specimen, 2020, New England Journal of Medicine

Collaborators commonly working with Francisco M. Marty included Matthew P. Cheng, Isabel H Gonzalez-Bocco, Muneerah M Aleissa, Sarah P. Hammond, and Kaiwen Chen.

Best Publications

  • Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

    Unknown

  • Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.

    Jason D. Goldman;David C.B. Lye;David S. Hui;Kristen M. Marks

  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.

    Christoph D. Spinner;Robert L. Gottlieb;Gerard J. Criner;José Ramón Arribas López

  • Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

    Francisco M Marty;Per Ljungman;Roy F Chemaly;Johan Maertens

  • Isavuconazole Treatment for Mucormycosis: A Single-Arm Open-Label Trial and Case-Control Analysis

    Francisco M. Marty;Luis Ostrosky-Zeichner;Oliver A. Cornely;Kathleen M. Mullane

  • Transmission of lymphocytic choriomeningitis virus by organ transplantation.

    Staci A. Fischer;Mary Beth Graham;Matthew J. Kuehnert;Camille Nelson Kotton

  • Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell Transplants

    Francisco M Marty;Lisa A Cosimi;Lindsey R Baden

  • Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation: Report of 2 Cases

    Timothy J. Henrich;Emily Hanhauser;Francisco M. Marty;Michael N. Sirignano

  • CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

    Francisco M. Marty;Drew J. Winston;Scott D. Rowley;Estil Vance

  • Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

    Francisco M. Marty;Per Ljungman;Genovefa A. Papanicolaou;Drew J. Winston

  • Persistent and relapsing babesiosis in immunocompromised patients.

    Peter J. Krause;Benjamin E. Gewurz;Benjamin E. Gewurz;David Hill;Francisco M. Marty

  • Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial

    Unknown

  • Post-transplant acute limbic encephalitis: Clinical features and relationship to HHV6

    W. W. Seeley;F. M. Marty;T. M. Holmes;K. Upchurch

  • Infectious complications associated with alemtuzumab use for lymphoproliferative disorders.

    Stanley I. Martin;Francisco M. Marty;Karen Fiumara;Steven P. Treon;Steven P. Treon

  • Diagnostic Performance of the (1→3)-β-d-Glucan Assay for Invasive Fungal Disease

    Sophia Koo;Sophia Koo;Julie M. Bryar;Julie M. Bryar;John H. Page;Lindsey R. Baden;Lindsey R. Baden

  • Three Patients with Full Facial Transplantation

    Bohdan Pomahac;Julian Joseph Pribaz;Elof Eriksson;Ericka Bueno

  • Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.

    Francisco M. Marty;Stephanie J. Lee;Michelle M. Fahey;Edwin P. Alyea

  • Emergence of a Clinical Daptomycin-Resistant Staphylococcus aureus Isolate during Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis

    Francisco M. Marty;Wendy W. Yeh;Christine B. Wennersten;Lata Venkataraman

  • How to Obtain a Nasopharyngeal Swab Specimen.

    Francisco M Marty;Kaiwen Chen;Kelly A Verrill

  • Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: A randomized, dose-ranging, double-blind, phase 2 study

    Genovefa A Papanicolaou;Fernanda P Silveira;Amelia A Langston;Marcus R Pereira

  • Serious Infections Among Adult Medicaid Beneficiaries With Systemic Lupus Erythematosus and Lupus Nephritis

    Candace H. Feldman;Linda T. Hiraki;Wolfgang C. Winkelmayer;Francisco M. Marty

  • Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation

    Timothy J. Henrich;Emily Hanhauser;Francisco M. Marty;Michael N. Sirignano

Frequent Co-Authors

Lindsey R. Baden
Lindsey R. Baden Brigham and Women's Hospital
Joseph H. Antin
Joseph H. Antin Dana-Farber Cancer Institute
Robert J. Soiffer
Robert J. Soiffer Harvard University
Vincent T. Ho
Vincent T. Ho Harvard University
Michael Boeckh
Michael Boeckh Fred Hutchinson Cancer Research Center
Corey Cutler
Corey Cutler Harvard University
Edwin P. Alyea
Edwin P. Alyea Harvard University
John Koreth
John Koreth Harvard University
Stefan G. Tullius
Stefan G. Tullius Brigham and Women's Hospital
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to various related fields and career pathways, many of which can be completed online. For example, healthcare administration roles often benefit from certifications such as the accredited fast medical billing and coding certificate online, which provides specialized skills for efficient healthcare data management.

If you’re interested in expanding your medical knowledge, you may explore options like a what medical degree can i get online to understand the landscape of online medical programs available today. These programs offer flexibility for working professionals and can complement a microbiology background.

Public health is another promising area linked to microbiology, especially with growing global health concerns. Many students choose to pursue an online mph programs easy to get into, allowing them to develop essential skills for disease prevention and health promotion in diverse communities.

Additionally, for those interested in child development and healthcare, obtaining a ccls certification can lead to rewarding careers supporting children in medical settings, integrating knowledge from microbiology with psychosocial care.

Best Scientists Citing Francisco M. Marty

Recently Published Articles